Endocrinology, Vol 123, 2571-2577, Copyright © 1988 by Endocrine Society

ARTICLES

Cyclosporin-A in vivo produces severe osteopenia in the rat: effect of dose and duration of administration

C Movsowitz, S Epstein, M Fallon, F Ismail and S Thomas
Division of Endocrinology and Metabolism, Albert Einstein Medical Center, Philadelphia, Pennsylvania 19141.

Cyclosporin-A (CsA) inhibits the in vitro bone-resorbing effects of cytokines. We investigated the in vivo effects of CsA on rat bone mineral metabolism. Three groups of male Sprague-Dawley rats were administered vehicle or low dose (7.5 mg/kg) or high dose (15 mg/kg) CsA for 14 and 28 days. Ionized calcium, PTH, serum bone Gla protein, blood urea nitrogen, creatinine, magnesium, and 1,25-dihydroxyvitamin D were determined serially. No significant changes in calciotropic hormones or renal function were noted. Significant bone resorption and trabecular bone loss occurred in the high dose group by day 14 and in both groups by day 28. Bone Gla protein was significantly increased within 2 weeks in both dosage groups (P less than 0.005), reflecting increased bone remodeling. CsA in vivo resulted in an unexpected and significant increase in bone remodeling, with striking bone loss. These effects are dependent on the duration and dose of CsA and appear to be mediated at a local level.

This article has been cited by other articles:

				U. Kunzendorf, B. K. Kramer, W. Arns, J. Braun, J. Grossmann, F. Pietruck, H. Schmidt-Gayk, A. Schwarz, E. Ziegler, H. Sperschneider, et al. Bone disease after renal transplantation Nephrol. Dial. Transplant., February 1, 2008; 23(2): 450 - 458. [Full Text] [PDF]

				J. R. Weisinger, R. G. Carlini, E. Rojas, and E. Bellorin-Font Bone Disease after Renal Transplantation Clin. J. Am. Soc. Nephrol., November 1, 2006; 1(6): 1300 - 1313. [Abstract] [Full Text] [PDF]

				B. O. Cetinkaya, G. Acikcoz, G. C. Keles, B. Ayas, and A. Korkmaz The Effect of Cyclosporin A on Alveolar Bone in Rats Subjected to Experimental Periodontal Disease Toxicol Pathol, October 1, 2006; 34(6): 716 - 722. [Abstract] [Full Text] [PDF]

				N. M. Maalouf and E. Shane Osteoporosis after Solid Organ Transplantation J. Clin. Endocrinol. Metab., April 1, 2005; 90(4): 2456 - 2465. [Abstract] [Full Text] [PDF]

				Y. Moz, R. Levi, V. Lavi-Moshayoff, K. B. Cox, J. D. Molkentin, J. Silver, and T. Naveh-Many Calcineurin A{beta} Is Central to the Expression of the Renal Type II Na/Pi Co-transporter Gene and to the Regulation of Renal Phosphate Transport J. Am. Soc. Nephrol., December 1, 2004; 15(12): 2972 - 2980. [Abstract] [Full Text] [PDF]

				T. Kawahara, S. Murakami, Y. Noiri, A. Ehara, N. Takemura, S. Furukawa, and S. Ebisu Effects of Cyclosporin-A-induced Immunosuppression on Periapical Lesions in Rats Journal of Dental Research, September 1, 2004; 83(9): 683 - 687. [Abstract] [Full Text] [PDF]

				R. G. Erben, K. S. Brunner, B. Breig, J. Eberle, M. Goldberg, and L. C. Hofbauer Skeletal Effects of Cyclosporin A Are Gender Related in Rats Endocrinology, January 1, 2003; 144(1): 40 - 49. [Abstract] [Full Text] [PDF]

				A. Fornoni, F. Cornacchia, G. A. Howard, B. A. Roos, G. E. Striker, and L. J. Striker Cyclosporin A affects extracellular matrix synthesis and degradation by mouse MC3T3-E1 osteoblasts in vitro Nephrol. Dial. Transplant., March 1, 2001; 16(3): 500 - 505. [Abstract] [Full Text] [PDF]

				G. R. Hetzel, J. Malms, P. May, P. Heering, A. Voiculescu, U. Modder, and B. Grabensee Post-transplant distal-limb bone-marrow oedema: MR imaging and therapeutic considerations Nephrol. Dial. Transplant., November 1, 2000; 15(11): 1859 - 1864. [Abstract] [Full Text] [PDF]

				M.-C. MONIER-FAUGERE, H. MAWAD, Q. QI, R. M. FRIEDLER, and H. H. MALLUCHE High Prevalence of Low Bone Turnover and Occurrence of Osteomalacia after Kidney Transplantation J. Am. Soc. Nephrol., June 1, 2000; 11(6): 1093 - 1099. [Abstract] [Full Text]

				K. K. Miller and A. Klibanski Amenorrheic Bone Loss J. Clin. Endocrinol. Metab., June 1, 1999; 84(6): 1775 - 1783. [Full Text]

				J. Cremer, M. Struber, I. Wagenbreth, J. Nischelsky, S. Demertzis, T. Graeter, C. Abraham, and A. Haverich Progression of steroid-associated osteoporosis after heart transplantation Ann. Thorac. Surg., January 1, 1999; 67(1): 130 - 133. [Abstract] [Full Text] [PDF]

				M. Abdelhadi and J. Nordenström Bone Mineral Recovery after Parathyroidectomy in Patients with Primary and Renal Hyperparathyroidism J. Clin. Endocrinol. Metab., November 1, 1998; 83(11): 3845 - 3851. [Abstract] [Full Text]

				E. Shane, M. Rivas, D. J. McMahon, R. B. Staron, S. J. Silverberg, M. J. Seibel, D. Mancini, R. E. Michler, K. Aaronson, V. Addesso, et al. Bone Loss and Turnover after Cardiac Transplantation J. Clin. Endocrinol. Metab., May 1, 1997; 82(5): 1497 - 1506. [Abstract] [Full Text] [PDF]